Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Sesen Bio Inc | SESN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.0176 | -1.61% | 1.0724 | 1.10 | 1.03 | 1.10 | 1.09 | 11:12:04 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 1.07 | 1.08 | 0.01 | 0.93% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 897 | 735,607 | $ 1.07 | $ 789,292 | 1,718,418 | 0.6609 - 2.64 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 11:12:04 | 1,000 | $ 1.0724 | USD |
Sesen Bio Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 112.26M | 104.68M | $ -33.69M | -0.52 | - | 103.58M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | 1.00% |
Sesen Bio News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SESN Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.18 | 1.27 | 1.03 | 1.13 | 1,761,058 | -0.1076 | -9.12% |
| 1 Month | 1.14 | 1.38 | 1.03 | 1.18 | 1,450,741 | -0.0676 | -5.93% |
| 3 Months | 1.09 | 1.55 | 1.03 | 1.21 | 1,254,903 | -0.0176 | -1.61% |
| 6 Months | 1.91 | 1.95 | 1.02 | 1.29 | 1,457,345 | -0.8376 | -43.85% |
| 1 Year | 1.53 | 2.64 | 0.6609 | 1.35 | 1,892,358 | -0.4576 | -29.91% |
| 3 Years | 2.14 | 3.50 | 0.6201 | 1.67 | 1,482,158 | -1.07 | -49.89% |
| 5 Years | 11.51 | 13.79 | 0.2511 | 1.98 | 1,346,562 | -10.44 | -90.68% |
Sesen Bio Description
| Sesen Bio Inc is a late-stage clinical company engaged in next-generation antibody-drug conjugate therapies for the treatment of cancer based on the company's Targeted Protein Therapeutics platform. The company's lead program, Vicinium, also known as VB4-845, is currently in a Phase 3 registration trial, the VISTA Trial, for the treatment of high-grade non-muscle invasive bladder cancer. |
